ERIN LECHNER: Open Payments
NPI 1538539002 · MAXWELL AFB, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,073 in 93 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $161 · 2025 $2,073
Food & beverage: $2,073
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $382 |
| AstraZeneca Pharmaceuticals LP | 6 | $296 |
| Corcept Therapeutics | 7 | $202 |
| Axsome Therapeutics, Inc. | 6 | $163 |
| Novo Nordisk Inc | 7 | $136 |
| Lilly USA, LLC | 7 | $132 |
| GlaxoSmithKline, LLC. | 7 | $126 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $97 |
| Amgen Inc. | 5 | $84 |
| PFIZER INC. | 4 | $79 |
Products named: AIRSUPRA, Korlym, VRAYLAR, JARDIANCE, Auvelity, QULIPTA, Wegovy, FARXIGA.
Industry payments across AL — which companies pay providers there.
